Cargando…

Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase

SARS-CoV-2, a member of the coronavirus family, is responsible for the current COVID-19 pandemic. Based on our analysis of hepatitis C virus and coronavirus replication, and the molecular structures and activities of viral inhibitors, we previously demonstrated that three nucleotide analogues inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chien, Minchen, Anderson, Thomas K., Jockusch, Steffen, Tao, Chuanjuan, Kumar, Shiv, Li, Xiaoxu, Russo, James J., Kirchdoerfer, Robert N., Ju, Jingyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239050/ https://www.ncbi.nlm.nih.gov/pubmed/32511320 http://dx.doi.org/10.1101/2020.03.18.997585

Ejemplares similares

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
por: Ju, Jingyue, et al.
Publicado: (2020)

A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19
por: Jockusch, Steffen, et al.
Publicado: (2020)

Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
por: Jockusch, Steffen, et al.
Publicado: (2020)

Identifying Structural Features of Nucleotide Analogues to Overcome SARS-CoV-2 Exonuclease Activity
por: Wang, Xuanting, et al.
Publicado: (2022)

Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
por: Wang, Xuanting, et al.
Publicado: (2021)

Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
por: Wang, Xuanting, et al.
Publicado: (2022)

PEG-Labeled Nucleotides and Nanopore Detection for Single Molecule DNA Sequencing by Synthesis
por: Kumar, Shiv, et al.
Publicado: (2012)

The nucleotide addition cycle of the SARS-CoV-2 polymerase
por: Bera, Subhas Chandra, et al.
Publicado: (2021)

The nucleotide addition cycle of the SARS-CoV-2 polymerase
por: Bera, Subhas Chandra, et al.
Publicado: (2021)

Molecular beacons with intrinsically fluorescent nucleotides
por: Martí, Angel A., et al.
Publicado: (2006)

Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
por: Nguyenla, Xammy, et al.
Publicado: (2022)

A Systematic Study on the Optimal Nucleotide Analogue Concentration and Rate Limiting Nucleotide of the SARS-CoV-2 RNA-Dependent RNA Polymerase
por: Vatandaslar, Hasan
Publicado: (2022)

Inhibition of SARS-CoV-2 polymerase by nucleotide analogs: a single molecule perspective
por: Seifert, Mona, et al.
Publicado: (2021)

Probing remdesivir nucleotide analogue insertion to SARS-CoV-2 RNA dependent RNA polymerase in viral replication
por: Romero, Moises E., et al.
Publicado: (2022)

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
por: Kirchdoerfer, Robert N., et al.
Publicado: (2019)

Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective
por: Seifert, Mona, et al.
Publicado: (2021)

Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2
por: Conti, Brian J., et al.
Publicado: (2021)

Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues
por: Daikopoulou, Vasiliki, et al.
Publicado: (2021)

Halting coronavirus polymerase
por: Kirchdoerfer, Robert N.
Publicado: (2020)

Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication
por: Dejmek, Milan, et al.
Publicado: (2021)

Prognostic Values of microRNAs in Colorectal Cancer
por: Xi, Yaguang, et al.
Publicado: (2007)

Pyrene binary probes for unambiguous detection of mRNA using time-resolved fluorescence spectroscopy
por: Martí, Angel A., et al.
Publicado: (2006)

A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase
por: Khan, Suliman, et al.
Publicado: (2021)

Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2
por: Shannon, Ashleigh, et al.
Publicado: (2023)

An alphacoronavirus polymerase structure reveals conserved co-factor functions
por: Anderson, Thomas K., et al.
Publicado: (2023)

In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
por: Cetin, Adnan
Publicado: (2021)

Nucleotide Analogues Bearing a C2′ or C3′-Stereogenic All-Carbon Quaternary Center as SARS-CoV-2 RdRp Inhibitors †
por: Manchoju, Amarender, et al.
Publicado: (2022)

Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors
por: Ullrich, Sven, et al.
Publicado: (2021)

Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides
por: Wang, Bing, et al.
Publicado: (2021)

Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus
por: Feng, Joy Y., et al.
Publicado: (2016)

(1)H, (13)C, and (15)N backbone and side chain chemical shift assignments of the SARS-CoV-2 non-structural protein 7
por: Tonelli, Marco, et al.
Publicado: (2020)

Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach
por: Farhat, Ameny, et al.
Publicado: (2022)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
por: Neogi, Ujjwal, et al.
Publicado: (2020)

Inhibition of the RNA-Dependent RNA-Polymerase from SARS-CoV-2 by 6-Chloropurine Isoxazoline-Carbocyclic Monophosphate Nucleotides
por: Leusciatti, Marco, et al.
Publicado: (2023)

Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues
por: Min, Long, et al.
Publicado: (2022)

Inhibition of the RNA-dependent RNA Polymerase of the SARS-CoV-2 by Short Peptide Inhibitors
por: Pant, Suyash, et al.
Publicado: (2021)

Subtle structural differences of nucleotide analogs may impact SARS-CoV-2 RNA-dependent RNA polymerase and exoribonuclease activity
por: Madariaga-Mazón, Abraham, et al.
Publicado: (2022)

Chitosan nanoparticles for the intracellular delivery of triphosphate nucleotide analogues
por: Giacalone, Giovanna, et al.
Publicado: (2014)

Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants
por: Ferdous, Nadim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vqqq7iaodjrggn0f8tptfrovdr